Journal
GLAND SURGERY
Volume 3, Issue 4, Pages 258-275Publisher
AME PUBL CO
DOI: 10.3978/j.issn.2227-684X.2014.06.03
Keywords
Pancreatic neuroendocrine tumor (pNET); pancreas; neuroendocrine neoplasm; islet cell tumor; surgical therapy; liver metastases; targeted therapy; laparoscopic pancreas surgery; pancreas cancer
Categories
Ask authors/readers for more resources
Pancreatic neuroendocrine tumors (pNETs) are relatively rare tumors comprising 1-2% of all pancreas neoplasms. In the last 10 years our understanding of this disease has increased dramatically allowing for advancements in the treatment of pNETs. Surgical excision remains the primary therapy for localized tumors and only potential for cure. New surgical techniques using laparoscopic approaches to complex pancreatic resections are a major advancement in surgical therapy and increasingly possible. With early detection being less common, most patients present with metastatic disease. Management of these patients requires multidisciplinary care combining the best of surgery, chemotherapy and other targeted therapies. In addition to surgical advances, recently, there have been significant advances in systemic therapy and targeted molecular therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available